HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Thyroid cancer is a relatively uncommon but typically treatable malignancy that originates in the cells of the thyroid gland, a butterfly-shaped organ located at the base of the neck. The most common types of thyroid cancer include papillary carcinoma and follicular carcinoma, which generally have favorable prognoses. Thyroid cancer often presents as a painless lump or nodule in the thyroid gland, and while the majority of thyroid nodules are non-cancerous, thorough evaluation is crucial for accurate diagnosis. Diagnostic methods may include fine-needle aspiration biopsy, imaging studies like ultrasound, and blood tests to assess thyroid function.
Treatment for thyroid cancer varies based on the type and stage of the disease. The primary modalities include surgery to remove the thyroid gland (thyroidectomy), radioactive iodine therapy to eliminate remaining thyroid tissue or cancer cells, and, in some cases, hormone replacement therapy to maintain thyroid function. The overall outlook for thyroid cancer is generally favorable, with high survival rates, particularly for well-differentiated forms. Regular follow-up care and monitoring are essential to detect any recurrence or residual disease, emphasizing the importance of a multidisciplinary approach involving endocrinologists, surgeons, and oncologists in the comprehensive management of thyroid cancer.
